Frontiers in Pharmacology | Inflammation Pharmacology

Review

Accepted on 25 Jun 2025

Research Progress in Treatment of Rheumatoid Arthritis with Sinomenine and Related Formulations Based on Different Administration Routes

in Inflammation Pharmacology

Wenya Wang
Zihui Wang
Aixia Ling
Chunyan Zhang
Mei Lv
Lufen Huang
Yanlian Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1613679

Original Research

Published on 25 Jun 2025

Anti atherosclerosis effect and mechanism of a novel curcumin analogue CACN136: regulating macrophage M1/M2 polarization and lipid metabolism

in Inflammation Pharmacology

Qianjiao Zhao
Yueting Zhong
Zheng Li
Jia Tang
Chao Pi
Wenwu Zheng
Peng Shi
Ying Zuo
Jun Jiang
Yan Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632647

224 views

Original Research

Published on 25 Jun 2025

Impact of different treatment strategies on therapeutic efficacy and biomarkers in children with IVIG-resistant Kawasaki disease: a retrospective cohort study

in Inflammation Pharmacology

Xin Zhou
Rui Dong
Xiaoling Wei
Hao Ding
Xiaochen Wang
Wei Wu
Guiyun Kang
Lei Li
Xiang Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602637

248 views

Original Research

Published on 25 Jun 2025

Dexmedetomidine reduces acute lung injury caused by LPS through the SIRT3 signaling pathway in vivo

in Inflammation Pharmacology

Jian Chen
Yang Cai
Xiaochun Peng
Yuanling Xu
Liying Chen
Xinxin Pan
Yingying Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1524219

164 views

Systematic Review

Published on 23 Jun 2025

Safety profile and dose-dependent adverse events of upadacitinib in randomized clinical trials: a systematic review and meta-analysis

in Inflammation Pharmacology

Cong Zhang
Zhiwen Fu
Jinmei Liu
Shijun Li
Xu Chen
Yi Zhang
Jiyi Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598972

270 views

Correction

Accepted on 20 Jun 2025

"Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations"

in Inflammation Pharmacology

Lingli Wang
Fengsong Nie
Zhaoyu Lu
Yang Chong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1646006

189 views

Original Research

Accepted on 19 Jun 2025

Protective Effects of Salubrinal Against H2O2-Induced Muscle Wasting via eIF2α/ATF4 Signaling Pathway

in Inflammation Pharmacology

Siming Lin
Jingying Wu
Guili Lian
Weibin Wu
Weixiao Chen
Ai Chen
Li Luo
Liangdi Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1607606

Editorial

Published on 19 Jun 2025

Editorial: Purinergic signaling in metabolic diseases and inflammation pharmacology

in Inflammation Pharmacology

Alejandro Sánchez-Melgar
Juana Maria Sanz
Anna Lisa Giuliani

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1631388

334 views

Original Research

Accepted on 18 Jun 2025

Antagonizing IL-6 receptor restores pancreatic tissue resident NK cells activation and ameliorates pancreatic injury in the mouse model of MASH

in Inflammation Pharmacology

Johnny Amer
Diana Abu Arra
Ahmad Salhab
Faris Kayed
Muneer Maali
Raghad Shweiki
Mustafa Ghanim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611637

169 views

Original Research

Published on 18 Jun 2025

Intracerebroventricular calycosin attenuates cerebral ischemia-reperfusion injury in rats via HMGB1-dependent pyroptosis inhibition

in Inflammation Pharmacology

Yuhui Zhang
Qiguang Wu
Yanjin Pan
Min Xin
Wenbo Wang
Xiaoya Zhai
Peiquan Zhou
Chong Zhang
Yong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596087

400 views

Original Research

Published on 18 Jun 2025

SIRT2-dependent CPT1A deacetylation in macrophages inhibits periodontitis

in Inflammation Pharmacology

Yixuan Jiang
Xiu Yao
Zhizhong Jiang
Xiaomeng Liu
Boyuan Sun
Zhengyu Guan
Lin Zhou
Hongjiao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1574141

212 views

Systematic Review

Accepted on 17 Jun 2025

Immunomodulatory Effects of Ulinastatin Combined with Continuous Blood Purification in Sepsis: A Systematic Review and Meta-Analysis

in Inflammation Pharmacology

Hui Gao
Zhiqiang Tang
Shucheng Zhao
Yuanjun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591470

100 views

Correction

Published on 17 Jun 2025

Correction: Ginsenoside compound K attenuates Ox-LDL-mediated macrophage inflammation and foam cell formation via autophagy induction and modulating NF-κB, p38, and JNK MAPK signaling

in Inflammation Pharmacology

Shan Lu
Yun Luo
GuiBo Sun
XiaoBo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1499242

261 views

Original Research

Published on 13 Jun 2025

AduCPI2 alleviates MSU-induced acute gouty arthritis in mice by inhibiting cathepsin S and the C5a-C5aR1 axis

in Inflammation Pharmacology

Sijing Liu
Yongli Situ
Li Deng
Meng Liang
Haoyuan He
Zheng Shao
Lifei Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604329

399 views

Review

Published on 13 Jun 2025

Salt sensitivity and myocardial fibrosis: unraveling the silent cardiovascular remodeling

in Inflammation Pharmacology

Katongo Hope Mutengo
Owen Ngalamika
Annet Kirabo
Sepiso K. Masenga

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1626492

642 views

Original Research

Published on 11 Jun 2025

Urinary urodilatin levels in patients with renal salt wasting syndrome as a possible new diagnostic marker. A pilot study

in Inflammation Pharmacology

Vittoriano Della Corte
Luisa Agnello
Rosario Norrito
Marco Cataldi
Fabio Del Ben
Rosaria Pecoraro
Carlo Maida
Caterina Maria Gambino
Mario Daidone
Rosaria Vincenza Giglio

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579699

384 views